Resmed Inc Stock Analysis

ResMed Stock Analysis Notes

About 67.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.74. ResMed Inc recorded earning per share (EPS) of 10.1. The entity last dividend was issued on the 12th of February 2026. The firm had 2:1 split on the 31st of August 2010. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people. To find out more about ResMed Inc contact BE MBA at 858-836-5000 or learn more at https://www.resmed.com.

ResMed Inc Investment Alerts

ResMed Largest EPS Surprises

View All Earnings Estimates

ResMed Environmental, Social, and Governance (ESG) Scores

ResMed Thematic Classifications

ResMed Stock Institutional Investors

Note, although ResMed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ResMed Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 39.65 B.

ResMed Profitablity

The company has Net Profit Margin of 0.28 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.35 %, which entails that for every 100 dollars of revenue, it generated $0.35 of operating income.

Management Efficiency

ResMed Inc has Return on Asset of 0.1475 % which means that on every $100 spent on assets, it made $0.1475 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2568 %, implying that it generated $0.2568 on every 100 dollars invested. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.28, whereas Return On Capital Employed is forecasted to decline to 0.14. At present, ResMed's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 121.7 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 42.6 M.

Technical Drivers

As of the 8th of February, ResMed holds the Semi Deviation of 1.16, risk adjusted performance of 0.0878, and Coefficient Of Variation of 963.99. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Please check ResMed Inc information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 271.63 per share. Given that ResMed has jensen alpha of 0.0726, we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.

ResMed Inc Price Movement Analysis

ResMed Inc Insider Trading Activities

ResMed Outstanding Bonds

ResMed Predictive Daily Indicators

ResMed Corporate Filings

ResMed Forecast Models

ResMed's time-series forecasting models are one of many ResMed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ResMed Bond Ratings

ResMed Inc financial ratings play a critical role in determining how much ResMed have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for ResMed's borrowing costs.

ResMed Inc Debt to Cash Allocation

ResMed Inc has 851.81 M in debt with debt to equity (D/E) ratio of 0.27, which may show that the company is not taking advantage of profits from borrowing. ResMed Inc has a current ratio of 2.74, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. That said, strategic use of leverage may enable ResMed to fund expansion initiatives and generate superior returns.

ResMed Total Assets Over Time

ResMed Assets Financed by Debt

The debt-to-assets ratio shows the degree to which ResMed uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

ResMed Debt Ratio

13.0

It looks as if most of the ResMed's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the ResMed's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of ResMed, which in turn will lower the firm's financial flexibility.

ResMed Corporate Bonds Issued

ResMed Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how ResMed prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ResMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ResMed. By using and applying ResMed Stock analysis, traders can create a robust methodology for identifying ResMed entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ResMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ResMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ResMed Inc stock analysis indicators help investors evaluate how ResMed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ResMed shares will generate the highest return on investment. By understating and applying ResMed stock analysis, traders can identify ResMed position entry and exit signals to maximize returns.

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.